Key Points for Quality Evaluation of Biological Reagents and Selection of In Vitro Diagnostic Raw Materials

Main Categories and Diagnostic Applications of Biological Reagents

Biological reagents generally refer to bioactive materials used in life science research, in vitro diagnostics, and biopharmaceutical processes, commonly in the form of liquids, lyophilized powders, or premixed solutions. Depending on their intended use, they can be broadly classified into molecular biology reagents, immunological reagents, cell biology reagents, and biochemical detection reagents. In the field of in vitro diagnostics, biological reagents often serve as core raw materials or key components, participating in enzymatic reactions, antigen-antibody binding, nucleic acid amplification, and signal amplification. Because in vitro diagnostics demand high result stability and reproducibility, the quality of biological reagents directly affects the overall performance of the detection system. Therefore, understanding their classification and compatibility logic is the first step in raw material selection and quality control.

Key Dimensions to Consider in Quality Evaluation

Quality evaluation is not about examining a single indicator but requires establishing a multi-dimensional assessment framework. Common test items include protein purity, nucleic acid purity, enzyme activity, antibody affinity, endotoxin levels, host protein residues, and functional validation. For molecular diagnostic enzymes, attention is generally paid to amplification efficiency, fidelity, batch-to-batch activity, and inhibition resistance; for antibodies or antigens used in immunodiagnostics, focus is placed on specificity, affinity, pairing performance, and behavior in different matrices. In addition, stability data are also critical, including freeze-thaw stability, short-term thermal stability, long-term storage stability, and shelf life after reconstitution. During evaluation, it is recommended to conduct simulation tests using the actual reaction system rather than relying solely on the certificate of analysis provided by the supplier.

Activity validation: perform gradient testing using a buffer system similar to the terminal reaction

Purity and residues: monitor common residues such as host proteins, nucleases, and endotoxins

Stability: examine key performance changes under freeze-thaw, short-term storage, and accelerated conditions

Compliance Requirements and Supply Stability

For biological reagents intended for registration submissions or clinical research, suppliers are typically required to have a stable quality management system and to provide batch inspection records, raw material source documentation, and necessary change management mechanisms. For critical raw materials, it is advisable to evaluate their process scale-up capability, consistency across multiple batches, and whether there is a single-source risk. In some application scenarios, attention should also be paid to animal-derived components, preservative types, and packaging container compatibility. To reduce the impact of supply interruptions on project timelines, alternative raw materials can be identified early in development and subjected to parallel validation, while establishing technical response and issue traceability mechanisms with suppliers.

Practical Recommendations for Selection and Risk Control

The selection process can start from the terminal detection requirements by first determining key performance parameters, then confirming them through small-sample screening, gradient experiment optimization, and scale-up validation. For projects requiring long-term supply, it is recommended to incorporate batch-to-batch consistency, documentation completeness, and response speed into the scoring system. At the same time, attention should be paid to the effects of storage and shipping conditions on biological reagent activity, such as refrigeration, freezing, or light protection requirements. Overall, biological reagent selection is a process combining technical and supply chain considerations, and scientific evaluation can reduce the risk of later changes and improve product development efficiency.